|
|
|
Prenetics Global Ltd | 5.875% SERIES I NON-CUMULATIVE REDEEMABLE PREFERRED SHARES (PRE.PRI)
Prospectus excerpt: So long as any Series I Preferred Shares are outstanding, (i) no dividends or other distributions (other than dividends or distributions paid solely in shares of, or options, warrants or rights to subscribe for or purchase shares of, Fully Junior Shares) shall be declared or paid or set apart for payment and no other distribution shall be declared or paid or set apart for payment upon Junior Shares, nor (ii) shall any Junior Shares be redeemed, purchased or otherwise acquired (other than a redemption, purchase or other acquisition of Common Shares made for purposes of an employee incentive or benefit plan of the Company or any subsidiary of the Company) for any consideration (or any moneys be paid to or made available for a sinking fund for the redemption of any Junior Shares) by the Company, directly or indirectly (except by conversion into or exchange for Fully Junior Shares) ((i) and (ii) collectively, ÙDistributionsˆ), unless in each case (1) the dividends on all outstanding Series I Preferred Shares and any Parity Shares shall have been or contemporaneously are declared and paid or declared and a sum sufficient for the payment thereof set apart for payment for the latest completed Dividend Period, and, in the case of the Cumulative Shares, for all past Dividend Periods and (2) sufficient funds shall have been or contemporaneously are set apart for the payment of the dividends for the current Dividend Period with respect to the Series I Preferred Shares and the current dividend period with respect to such Parity Shares. Following the Issue Date and until December 31, 2020, Distributions declared or paid with respect to any fiscal quarter shall be less than, in the aggregate, 67% of the Company?s net income (ÙNet Incomeˆ), as determined in accordance with United States generally accepted accounting principles, during such fiscal quarter (such amount, the ÙDistributable Amountˆ), provided, that notwithstanding the foregoing, with respect to the first fiscal quarter immediately following March 18, 2016, the ÙDistributable Amountˆ shall be defined as the sum of (x) 67% of the Company?s Net Income during such fiscal quarter, plus (y) (A) 67% of the Company?s Net Income during the 2015 fiscal year, minus (B) the sum of (1) the aggregate amount of ordinary course quarterly cash dividends on the Common Shares paid during the 2015 fiscal year plus (2) the aggregate amount paid by the Company during the 2015 fiscal year to repurchase the Common Shares (the ÙInitial Distributable Amountˆ); provided, further, that if the Company does not make aggregate Distributions of all of the Distributable Amount during any fiscal quarter, such remaining amount shall carryover and be available for Distributions in subsequent fiscal quarters, regardless of the Company?s Net Income during such subsequent fiscal quarters. Full Prospectus PDF », Secondary Prospectus PDF », PRE Page »
Series: | I | Alternate symbology: | PRE-I, PRE-PI, PREprI | Redeemable?: | Yes | Call Date: | 4/29/2021 (Now Trading Post Call Date) | Perpetual?: | Yes | Cumulative?: | No | Liquidation Preference: | $25.00 | Original Coupon: | 5.875% | Pay Period: | Quarterly | Pay Dates: | 1-Mar, 1-Jun, 1-Sep, 1-Dec | CDx3 Compliance Rating: |
Learn PRE.PRI's Rating
|
|
Prenetics Global is a holding company. Through its subsidiary, Prenetics Holding Company Limited, Co. is a diagnostics and genetics testing products and services provider. Co.'s pipeline products and services include: ColoClear, which is a non-invasive fecal immunochemical test and multi-target stool-based DNA testing colorectal cancer screening test; Circle SnapShot, which is an off-the-shelf at-home blood test where individuals can get digital access to their own health information; and Circle One, F1x and Fem, which develop to provide its customers personalized nutrition, hair loss and sexual health products tailored to each of its customer's genetic variation and biology. Preferreds: PRE.PRC, PRE.PRD, PRE.PRE, PRE.PRF, PRE.PRG, PRE.PRH, PRE.PRI, PRE.PRJ Open the PRE Information Page »
|
|
|
|
|